Absence of Tumor Necrosis Factor Supports Alternative Activation of Macrophages in the Liver After Infection with
Overview
Affiliations
The absence of tumor necrosis factor (TNF) causes lethal infection by in normally resistant C57BL/6J (B6.WT) mice. The underlying pathogenic mechanism of this fatal disease has so far remained elusive. We found that B6.WT mice deficient for the gene (B6.TNF) displayed not only a non-healing cutaneous lesion but also a serious infection of the liver upon inoculation. Infected B6.TNF mice developed an enlarged liver that showed increased inflammation. Furthermore, we detected an accumulating monocyte-derived macrophage population (CD45F4/80CD11bLy6C) that displayed a M2 macrophage phenotype with high expression of CD206, arginase-1, and IL-6, supporting the notion that IL-6 could be involved in M2 differentiation. In experiments, we demonstrated that IL-6 upregulated M-CSF receptor expression and skewed monocyte differentiation from dendritic cells to macrophages. This was countered by the addition of TNF. Furthermore, TNF interfered with the activation of IL-6-induced gp130-signal transducer and activator of transcription (STAT) 3 and IL-4-STAT6 signaling, thereby abrogating IL-6-facilitated M2 macrophage polarization. Therefore, our results support the notion of a general role of TNF in the inflammatory activation of macrophages and define a new role of IL-6 signaling in macrophage polarization downstream of TNF.
From natural defenders to therapeutic warriors: NK cells in HIV immunotherapy.
Laeremans T, Janssens A, Aerts J Immunotherapy. 2025; 17(2):133-145.
PMID: 39905963 PMC: 11901454. DOI: 10.1080/1750743X.2025.2460965.
An untargeted metabolomic analysis of acute AFB1 treatment in liver, breast, and lung cells.
Cao H, Molina S, Sumner S, Rushing B PLoS One. 2025; 20(1):e0313159.
PMID: 39883710 PMC: 11781672. DOI: 10.1371/journal.pone.0313159.
Huang F Biomedicines. 2025; 12(12.
PMID: 39767818 PMC: 11673835. DOI: 10.3390/biomedicines12122912.
Radziszewska A, Peckham H, Restuadi R, Kartawinata M, Moulding D, de Gruijter N Clin Exp Immunol. 2024; 219(1).
PMID: 39719886 PMC: 11748002. DOI: 10.1093/cei/uxae127.
Whalen J, Chandra A, Kracker S, Ehl S, Seidel M, Gulas I Clin Exp Immunol. 2024; 219(1).
PMID: 39673396 PMC: 11754865. DOI: 10.1093/cei/uxae107.